Passer au contenu principal

Votre navigateur n’est malheureusement pas entièrement pris en charge. Si vous avez la possibilité de le faire, veuillez passer à une version plus récente ou utiliser Mozilla Firefox, Microsoft Edge, Google Chrome, ou Safari 14 ou plus récent. Si vous n’y parvenez pas et que vous avez besoin d’aide, veuillez nous faire part de vos commentaires.

Nous vous serions reconnaissants de nous faire part de vos commentaires sur cette nouvelle expérience.Faites-nous part de votre opinion S’ouvre dans une nouvelle fenêtre

Elsevier
Publier avec nous

ESMO Events 2025

Meetings S’ouvre dans une nouvelle fenêtre | ESMO S’ouvre dans une nouvelle fenêtre

Welcome to our ESMO Virtual Congress site where we showcase the very best from ESMO's flagship portfolio.

ESMO Gastrointestinal Cancers Congress 2025 S’ouvre dans une nouvelle fenêtre

This important event will bring together leading experts, researchers, and healthcare professionals dedicated to the advancement of gastrointestinal cancers treatment and care.

Through groundbreaking presentations, multidisciplinary tumour boards, controversy sessions, and more, attendees will have the opportunity to delve into the latest research findings, innovative therapeutic strategies, and emerging technologies that are shaping the future of GI cancers treatment.

The programme will cover a wide spectrum of topics, including molecular prevention, diagnosis, precision therapy, and patient-centered care approaches in the treatment of GI malignancies.

Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the themes of the meeting.

Annals of Oncology

  • Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population☆ S’ouvre dans une nouvelle fenêtre J.F. Seligmann, D. Morton, F. Elliott, K. Handley, R. Gray, M. Seymour, B. Glimelius, L. Magill, C.J.M. Williams, P. Quirke, D. Bottomley, H.M. Wood, K. Murakami, A.D. Beggs, N.P. West on behalf of the FOxTROT Collaborative Group

  • The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study S’ouvre dans une nouvelle fenêtre E. Rangelova, T.F. Stoop, T.M.E. van Ramshorst, M. Ali, E.A. van Bodegraven, A.A. Javed, D. Hashimoto, E. Steyerberg, A. Banerjee, A. Jain, A. Sauvanet, A. Serrablo, A. Giani, A. Giardino, A. Zerbi, A. Arshad, A.G. Wijma, A. Coratti, A. Zironda, A. Socratous, A. Rojas, A. Halimi, A. Ejaz, A. Oba, B.Y. Patel, B. Björnsson, B.N. Reames, B. Tingstedt, B.K.P. Goh, C. Payá-Llorente, C.D. Del Pozo, C. González-Abós, C. Medin, C.H.J. van Eijck, C. de Ponthaud, C. Takishita, C. Schwabl, C. Månsson, C. Ricci, C.A. Thiels, D. Douchi, D.L. Hughes, D. Kilburn, D. Flanking, D. Kleive, D.S. Silva, B.H. Edil, E. Pando, E. Moltzer, E.F. Kauffman, E. Warren, E. Bozkurt, E. Sparrelid, E. Thoma, E. Verkolf, F. Ausania, F. Giannone, F.J. Hüttner, F. Burdio, F.R. Souche, F. Berrevoet, F. Daams, F. Motoi, G. Saliba, G. Kazemier, G. Roeyen, G. Nappo, G. Butturini, G. Ferrari, G. Kito Fusai, G. Honda, G. Sergeant, H. Karteszi, H. Takami, H. Suto, I. Matsumoto, I. Mora-Oliver, I. Frigerio, J.M. Fabre, J. Chen, J.G. Sham, J. Davide, J. Urdzik, J. de Martino, K. Nielsen, K. Okano, K. Kamei, K. Okada, K. Tanaka, K.J. Labori, K.E. Goodsell, L. Alberici, L. Webber, L. Kirkov, L. de Franco, M. Miyashita, M. Maglione, M. Gramellini, M. Ramera, M.J. Amaral, M. Ramaekers, M.J. Truty, M.A. van Dam, M.W.J. Stommel, M. Petrikowski, M. Imamura, M. Hayashi, M. D’Hondt, M. Brunner, M.E. Hogg, C. Zhang, M.Á. Suárez-Muñoz, M.D. Luyer, M. Unno, M. Mizuma, M. Janot, M.A. Sahakyan, N.B. Jamieson, O.R. Busch, O. Bilge, O. Belyaev, O. Franklin, P. Sánchez-Velázquez, P. Pessaux, P.S. Holka, P. Ghorbani, R. Casadei, R. Sartoris, R.D. Schulick, R. Grützmann, R. Sutcliffe, R. Mata, R.B. Patel, R. Takahashi, S. Rodriguez Franco, S.S. Cabús, S. Hirano, S. Gaujoux, S. Festen, S. Kozono, S.K. Maithel, S.M. Chai, S. Yamaki, S. van Laarhoven, J.S.D. Mieog, T. Murakami, T. Codjia, T. Sumiyoshi, T.M. Karsten, T. Nakamura, T. Sugawara, U. Boggi, V. Hartman, V.E. de Meijer, W. Bartholomä, W. Kwon, Y.X. Koh, Y. Cho, Y. Takeyama, Y. Inoue, Y. Nagakawa, Y. Kawamoto, Y. Ome, Z. Soonawalla, K. Uemura, C.L. Wolfgang, J.Y. Jang, R. Padbury, S. Satoi, W. Messersmith, J.W. Wilmink, M. Abu Hilal, M.G. Besselink, M. Del Chiaro, for the European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS) the International Consortium on Advanced Pancreatic Surgery

  • Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials S’ouvre dans une nouvelle fenêtre H. Williams, E. Fokas, M. Diefenhardt, C. Lee, F.S. Verheij, D.M. Omer, S.T. Lin, R.F. Dunne, J. Marcet, P. Cataldo, B. Polite, P. Piso, B. Polat, H. Dapper, M. Ghadimi, R.D. Hofheinz, L.-X. Qin, L.B. Saltz, A.J. Wu, M.J. Gollub, J.J. Smith, M.R. Weiser, C. Rödel, J. Garcia-Aguilar, on behalf of the German Rectal Cancer Study Group and the OPRA Consortium

ESMO Open

Immuno-Oncology and Technology

ESMO Gastrointestinal Oncology

ESMO Real World Data and Digital Oncology

ESMO affiliated journals

ESMO's Journal Portfolio

While diverse in nature and in content, these journals offer ESMO members and the oncology community a highly visible platform to publish important scientific studies, and a highly credible source for educational updates. Elsevier is the proud publisher of Annals of Oncology, Immuno-Oncology and Technology (IOTECH), ESMO Open, ESMO Gastrointestinal Oncology, ESMO Real World Data and Digital Oncology, ESMO Rare Cancers, and ESMO Affiliated Journals The Breast, Lung Cancer, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia.

ESMO - European Society for Medical Oncology journals